Rhythm Pharmaceuticals, Inc. (BMV:RYTM)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,866.76
-158.24 (-7.81%)
At close: Nov 18, 2025

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue, Net
194.77M130.13M
Product Revenue, Net Growth
49.68%68.06%
License Revenue
-5.01M-
Revenue (Other)
--
Revenue (Total)
189.76M130.13M
Revenue (Total) Growth
45.83%68.06%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
License Revenue
-5.01M-
United States Revenue
133.55M96.11M
United States Revenue Growth
38.96%53.96%
International Revenue
-34.02M
International Revenue Growth
-126.74%
Revenue (Other)
61.22M-
Revenue (Total)
189.76M130.13M
Revenue (Total) Growth
45.83%68.06%
Updated Dec 31, 2025. Data Source: Fiscal.ai.